Spruce Biosciences, Inc.盘中异动早盘股价大涨6.46%报0.470美元

市场透视09-30

北京时间2024年09月30日22时03分，Spruce Biosciences, Inc.（SPRB.us）股票出现异动，股价急速上涨6.46%。截至发稿，该股报0.470美元/股，成交量32.6094万股，换手率0.79%，振幅4.12%。最近的财报数据显示，该股实现营业收入1.61百万美元，净利润-9.18百万美元，每股收益-0.22美元，毛利1.60百万美元，市盈率-0.44倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2471893933?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-30 22:03","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2471893933","market":"us","top_or_hot":-1,"title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.46%报0.470美元","media":"市场透视","content":"<div>\n<p>北京时间2024年09月30日22时03分，Spruce Biosciences, Inc.（SPRB.us）股票出现异动，股价急速上涨6.46%。截至发稿，该股报0.470美元/股，成交量32.6094万股，换手率0.79%，振幅4.12%。最近的财报数据显示，该股实现营业收入1.61百万美元，净利润-9.18百万美元，每股收益-0.22美元，毛利1.60百万美元，市盈率-0.44倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.46%报0.470美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpruce Biosciences, Inc.盘中异动 早盘股价大涨6.46%报0.470美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-30 22:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年09月30日22时03分，Spruce Biosciences, Inc.（SPRB.us）股票出现异动，股价急速上涨6.46%。截至发稿，该股报0.470美元/股，成交量32.6094万股，换手率0.79%，振幅4.12%。最近的财报数据显示，该股实现营业收入1.61百万美元，净利润-9.18百万美元，每股收益-0.22美元，毛利1.60百万美元，市盈率-0.44倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b","article_id":"2471893933","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2471893933","pubTimestamp":1727705020,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年09月30日22时03分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨6.46%。截至发稿，该股报0.470美元/股，成交量32.6094万股，换手率0.79%，振幅4.12%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","SPRB":"Spruce Biosciences, Inc."},"translate_title":"Spruce Biosciences, Inc. shares jumped 6.46% to $0.470 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SPRB":1},"content_text":"北京时间2024年09月30日22时03分，Spruce Biosciences, Inc.（SPRB.us）股票出现异动，股价急速上涨6.46%。截至发稿，该股报0.470美元/股，成交量32.6094万股，换手率0.79%，振幅4.12%。最近的财报数据显示，该股实现营业收入1.61百万美元，净利润-9.18百万美元，每股收益-0.22美元，毛利1.60百万美元，市盈率-0.44倍。机构评级方面，在所有4家参与评级的机构中，25%的券商给予买入建议，75%的券商给予持有建议，无券商给予卖出建议。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Prime Medicine, Inc.、Kezar Life Sciences, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为77.08%、28.63%、26.27%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 (To Pur Com)、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)、Plus Therapeutics, Inc.，振幅分别为38.89%、34.02%、28.10%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。 该公司最初正在开发其全资候选产品 tildacerfont，作为潜在的第一个非甾体疗法，为患有经典先天性肾上腺增生症（ CAH ）的患者提供显着改善的疾病控制并减轻类固醇负担。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2471893933"}

Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.46%报0.470美元

精彩评论

Spruce Biosciences, Inc.盘中异动早盘股价大涨6.46%报0.470美元